February 2008
February 1, 2008 Download print version
Top hospitals have 27 percent lower mortality, annual
HealthGrades study finds
Influenza-associated
pediatric mortality and Staphylococcus aureus co-infection
Don't be
a Super Bowl statistic; Stress of watching the big game can be
hazardous to heart, research suggests
Anti-malaria efforts yield
new success
MedAssets’ CrossWalk product enables accurate
and defensible pricing of medical supplies
Top hospitals have 27 percent lower
mortality, annual HealthGrades study finds
Patients treated at top-rated hospitals
nationwide are nearly one-third less likely to die, on average, than those
admitted to all other hospitals, according to a study released today by
HealthGrades, the leading independent healthcare ratings organization.
Patients who undergo surgery at these high-performing hospitals also have an
average five percent lower risk of complications during their stay,
researchers found. The annual HealthGrades Hospital Quality and Clinical
Excellence study, now in its sixth year, identifies hospitals in the top
five percent nationally in terms of mortality and complication rates for 27
procedures and diagnoses, from bypass surgery to total knee replacement.
Hospitals achieving this level of care are designated Distinguished
Hospitals for Clinical Excellence by HealthGrades and are identified on the
organization's consumer Web site, HealthGrades.com.
To name hospitals in the top five percent for
clinical excellence, the HealthGrades’ study analyzed nearly 41 million
hospitalizations during the years 2004, 2005 and 2006 at all 4,971 of the
nation’s nonfederal hospitals. Disparities in the hospitals care patients
receive, based simply on where they choose to seek treatment, highlight a
troubling phenomenon in the U.S. healthcare system: a persistent and
preventable gap between high-quality hospitals and the rest of the field.
The 2008 study found that 171,424 lives may have been saved and 9,671 major
complications avoided during the three years studied, had the quality of
care at all hospitals matched the level of those in the top five percent.
In comparing hospitals in the
top five percent, designated as Distinguished Hospitals for Clinical
Excellence, with all other hospitals, the HealthGrades study found: On
average, a 27 percent lower risk of inhospital risk-adjusted mortality was
experienced by Medicare patients at Distinguished Hospitals for Clinical
Excellence in the following procedures and diagnoses: cardiac surgery,
angioplasty and stent, heart attack, heart failure, atrial fibrillation,
chronic obstructive pulmonary disease, community-acquired pneumonia, stroke,
abdominal aortic aneurysm repair, bowel obstruction, gastrointestinal bleed,
pancreatitis, diabetic acidosis and coma, pulmonary embolism and sepsis.
Individuals can see how their local hospitals are
rated, and if they have been designated Distinguished Hospitals for Clinical
Excellence, for free at
http://www.healthgrades.com.
Influenza-associated pediatric mortality and
Staphylococcus aureus co-infection
CDC is
requesting that states report all cases of influenza-related pediatric
mortality during the 2007-2008 influenza season. This health advisory
contains updated information about influenza and bacterial co-infections in
children and provides interim testing and treatment recommendations. Since
2004, the Influenza-Associated Pediatric Mortality Surveillance System has
collected information on deaths among children due to laboratory-confirmed
influenza, including the presence of other medical conditions and bacterial
infections at the time of death. From October 1, 2006 through September 30,
2007, 73 deaths from influenza in children were reported to CDC from 39
state health departments and two city health departments. Data on the
presence (or absence) of bacterial co-infections were recorded for 69 of
these cases; 30 (44%) had a bacterial co-infection, and 22 (73%) of these 30
were infected with Staphylococcus aureus.
The
number of pediatric influenza-associated deaths reported during 2006-07 was
moderately higher than the number reported during the two previous
surveillance years; the number of these deaths in which pneumonia or
bacteremia due to S. aureus was noted represents a five-fold
increase. Of the 22 influenza deaths reported with S. aureus in
2006-2007, 15 children had infections with methicillin-resistant S.
aureus (MRSA). The median age of children with S. aureus
co-infection was older than children without S. aureus co-infection
(10 years versus 5 years) and children with co-infection were more likely to
have pneumonia and Acute Respiratory Distress Syndrome (ARDS). Influenza
strains isolated from these children were not different from common strains
circulating in the community, and the MRSA strains have been similar to
those associated with MRSA skin infection outbreaks in the U.S.
Healthcare providers should test persons hospitalized with respiratory
illness for influenza, including those with suspected community-acquired
pneumonia. Healthcare providers should be alerted to the possibility of
bacterial co-infection among children with influenza, and request bacterial
cultures if children are severely ill or when community-acquired pneumonia
is suspected. Healthcare providers should be aware of the prevalence of
methicillin-resistant S. aureas strains in their communities when
choosing empiric therapy for patients with suspected influenza-related
pneumonia. Clinicians, healthcare providers, and medical examiners are asked
to contact their local or state health department as soon as possible when
deaths among children associated with laboratory-confirmed influenza are
identified.
CDC requests that state health departments report all cases of pediatric
influenza-associated deaths to CDC through
http://sdn.cdc.gov and that
information about bacterial pathogens isolated from sterile sites and/or
from sputum or endotracheal aspirates be completed on the
Influenza-Associated Pediatric Mortality Surveillance System case report
form. If the influenza death was complicated by S. aureus infection, state
health departments are asked to please contact the clinical agency that
reported the case to determine if the S. aureus isolate is available. CDC
will receive S. aureus isolates in order to better characterize those S.
aureus isolates from children who have died from influenza. If you have any
questions about this Health Advisory, please call the Influenza Division,
Epidemiology and Prevention Branch at 404-639-3747.
Study finds patients
diagnosed with coronary heart disease continue poor diets
More than 13 million Americans have survived a heart attack or have been
diagnosed with coronary heart disease (CHD), the number one cause of death
in the United States. In addition to medications, lifestyle changes, such as
a healthy diet and exercise, are known to reduce the risk for subsequent
cardiac events. Despite this evidence, a high proportion of heart attack
survivors do not follow their doctor’s advice to adhere to a healthy diet,
according to researchers at the University of Massachusetts Medical School (UMMS).
Many studies have centered on determining dietary risk factors for
developing CHD, but few investigations have studied the diets of CHD
patients following diagnosis. In “Dietary Quality 1 Year after Diagnosis of
Coronary Heart Disease,” published in the February issue of the Journal
of the American Dietetic Association, researchers measured the diet
quality of 555 CHD patients one year after a diagnostic coronary
angiography. Using the Alternative Health Eating Index (AHEI) to assess diet
quality, they found that a high proportion of those patients had not made
the necessary improvements to their diets to help reduce the risk of a
secondary CHD event. Proven to be a strong predictor of CHD, the AHEI is a
measure that isolates dietary components that are most strongly linked to
CHD risk reduction. “This study found that CHD patients’ diets had not
improved in the year after being diagnosed,” said Yunsheng Ma, MD, PhD, MPH,
assistant professor of medicine and one of the study’s lead authors.
Of a maximum 80 points, which indicates the healthiest diet, the average
AHEI score was 30.8, with individual scores ranging between 5.1 and 69.8.
The mean AHEI score was poorer than scores reported for samples of healthy
individuals from the Health Professional’s Follow-up Study and the Nurses’
Health Study. In a previous study by Ma and colleagues, the AHEI of several
popular weight loss plans was calculated; the highest scoring diet was the
Ornish Diet (AHEI = 64.6) and lowest scoring diet was the Atkins diet (AHEI=
42.3). The fact that one year after a coronary event patients with known CHD
still have lower AHEI scores than these popular diets may be indicative of
the complex issues of effecting and sustaining behavioral change and the
confusion patients may face in navigating through dietary recommendations.
When examining AHEI components, only 12.4 percent of the participants met
the optimal daily consumption of vegetables and 7.8 percent for fruit. Only
8 percent of the patients met the cereal fiber recommendation, and 5.2
percent of the participants limited their trans-fat intake to 0.5 percent of
total calories or less. In addition, nearly 11 percent of calories were from
saturated fat (less than 7 percent is recommended), while total fiber was
only 16.8 grams per day (25 grams or less per day is recommended). The
researchers found that low dietary quality was associated with smoking,
lower educational levels, obesity, high-fat intake and a lower calorie
intake. On average, smokers scored six units lower than non-smokers;
participants with education beyond high school scored three units higher
than participants with a high school education; and obese participants
scored four units lower than normal weight or overweight participants.
“An overwhelming number of CHD patients, roughly 80 percent, do not attend
cardiac rehabilitation programs, which instruct CHD patients about proper
diet and exercise,” said Ira Ockene, MD, the David and Barbara Milliken
Professor of Preventive Cardiology and professor of medicine at UMMS and
cardiologist at UMass Memorial Medical Center. “Changing one’s eating habits
is a long-term process, and optimal care should include cardiac
rehabilitation and appointments with dietitians, which can build upon the
patient’s initial foundations to improve his or her diet and overall
health.”

Don't be a Super Bowl statistic; Stress of watching the
big game can be hazardous to heart, research suggests
Most sports fans can recall a close game that made their hearts skip a
figurative beat, but a new study suggests that the stressful emotions of big
contests may in fact increase the risk of chest pains or cardiac arrest in
spectators. Though the study examined the effects of World Cup soccer
matches on Germans, many cardiologists said the findings would apply equally
to viewers of the Super Bowl or other tension-drenched games. Doctors have
long suspected a link between sports-watching and heart trouble, but the new
report in the New England Journal of Medicine provides some of the
most solid evidence to date. An analysis of 4,279 heart patients in Bavaria
found that the rate of heart attacks among men was three times greater on
days when the German national team was playing than during other periods.
Experts said the lesson for Super Bowl Sunday is clear. Spectators with a
known heart condition, they warned, should make an extra effort to relax
during games and not overindulge in the usual offerings of alcohol and fatty
foods, which can quickly increase the risk of heart attack. Dr. Parag Patel,
head of the cardiac intensive care unit at Advocate Lutheran General
Hospital in Park Ridge, IL, said one of his patients had a heart attack in
2003 immediately after attending Game 6 of the Cubs' playoff series with the
Florida Marlins. Chicago blew a three-run lead late in that fateful match.
The patient recovered from his coronary. But Patel forbade him to watch Game
7 while he was treated in the hospital. "He just had to relax," Patel said.
"A lot of people felt heartbroken after that series, but he had the real
deal."
In a 2006 study German researchers recorded 43 heart events per day on
average during the World Cup period, compared with slightly fewer than 15
per day during normal times. The heart troubles patients experienced
included full cardiac arrest, prolonged chest pain, abnormal heart beat and
discharge of implantable defibrillators as a result of unusual heart
rhythms. Men suffered more game-day events than women, and people with a
known history of heart disease were hit especially hard. Those high-risk
patients sustained heart attacks on game days at a rate four times higher
than usual.
Scientists believe that stress can release adrenaline and other
hormones that result in higher blood pressure and heart rate, narrower
arteries and perhaps an increased tendency of blood to form clots that can
block coronary arteries. Eating, smoking and drinking alcohol during a game
also increase the danger for high-risk patients. Dr. John Barron, a
cardiologist at Loyola University Medical Center in Maywood, said he
sometimes advises heart patients to take more beta blockers before a big
game; the drugs blunt the effect of adrenaline on heart muscle and lower
blood pressure. It also helps to remember it's just a game. (The
Chicago Tribune) See
THIS LINK.
Dip once or dip twice?
From an
article by Harold McGee:
Our annual national snacking binge is almost here. It would take a very
large bowl indeed to hold all the guacamole mashed from the more than 100
million avocados that are consumed on
Super Bowl
Sunday. And guacamole is just one of many dips that will be shared around
the TV. Just in time, a scientific report has some new findings that may
cause football fans to take a second look at that communal bowl of dip. The
study, to be published later this year in the
Journal of
Food Safety,
is the only one I’ve ever seen to proclaim that it was inspired by an
episode of “Seinfeld.”
It was conducted as part of a
Clemson University
program designed to get undergraduate students involved in scientific
research. Prof. Paul L. Dawson, a food microbiologist, proposed it after he
saw a rerun of a 1993 “Seinfeld” show in which George Costanza is confronted
at a funeral reception by Timmy, his girlfriend’s brother, after dipping the
same chip twice. “Did, did you just double dip that chip?” Timmy asks
incredulously, later objecting, “That’s like putting your whole mouth right
in the dip!” Finally George retorts, “You dip the way you want to dip, I’ll
dip the way I want to dip,” and aims another used chip at the bowl. Timmy
tries to take it away, and the scene ends as they wrestle for it.
Professor Dawson told me
that he had expected to find little or no microbial transfer from mouth to
chip to dip, which would support George’s nonchalance. The results surprised
him. The team of nine students instructed volunteers to take a bite of a
wheat cracker and dip the cracker for three seconds into about a tablespoon
of a test dip. They then repeated the process with new crackers, for a total
of either three or six double dips per dip sample. The team then analyzed
the remaining dip and counted the number of aerobic bacteria in it.
There were six test dips: sterile water with three different degrees of
acidity, a commercial salsa, a cheese dip and chocolate syrup. On average,
the students found that three to six double dips transferred about 10,000
bacteria from the eater’s mouth to the remaining dip. Each cracker picked up
between one and two grams of dip. That means that sporadic double dipping in
a cup of dip would transfer at least 50 to 100 bacteria from one mouth to
another with every bite. The kind of dip made a difference in a couple of
ways. The more acidic water samples had somewhat fewer bacteria, and the
numbers of bacteria declined with time. But the acidic salsa picked up
higher initial numbers of bacteria than the cheese or chocolate, because it
was runny. The thicker the dip, the more stuck to the chip, and so the fewer
bacteria were left behind in the bowl.
Last year Professor Dawson published a paper on the five-second rule, which
states that food dropped on the floor can be safely eaten if you pick it up
before you can count to five. The rule turned out to be false. Professor
Dawson and his team write that the actual risks of double dipping are
“debatable” and depend on many unknowable factors. But it’s good to be aware
that sharing a bowl of dip can mean sharing more than we’d like. And
happily, the obvious preventive measure requires no deprivation, just a
newly focused snack category: one-dip chips, too small for two. (The New
York Times) See
THIS LINK.
FDA alerts healthcare providers to risk of suicidal
thoughts and behavior with antiepileptic medications
The U.S. Food and Drug Administration issued new information to healthcare
professionals to alert them about an increased risk of suicidal thoughts and
behaviors (suicidality) in patients who take drugs called antiepileptics to
treat epilepsy, bipolar disorder, migraine headaches, and other conditions.
An FDA analysis of suicidality reports from placebo-controlled studies of 11
antiepileptic drugs shows that patients taking these drugs have about twice
the risk of suicidal thoughts and behaviors (0.43 percent), compared with
patients receiving placebo (0.22 percent). This risk corresponds to an
estimated 2.1 per 1,000 more patients in the drug treatment groups who
experienced suicidality than in the placebo groups.
Patients who are currently taking antiepileptic medicines should not make
any changes without first talking to their healthcare provider. Healthcare
providers should notify patients, their families, and caregivers of the
potential for an increase in the risk of suicidal thoughts or behaviors so
that patients may be closely observed for notable changes in behavior. The
higher risk of suicidal thoughts and behaviors was observed at one week
after starting a drug and continued to at least 24 weeks. The results were
generally consistent among all the different drug products studied and were
seen in all demographic subgroups.
Antiepileptic drugs in the analyses included the following: Carbamazepine
(marketed as Carbatrol, Equetro, Tegretol, Tegretol XR); Felbamate (marketed
as Felbatol); Gabapentin (marketed as Neurontin); Lamotrigine (marketed as
Lamictal); Levetiracetam (marketed as Keppra); Oxcarbazepine (marketed as
Trileptal); Pregabalin (marketed as Lyrica); Tiagabine (marketed as Gabitril);
Topiramate (marketed as Topamax); Valproate (marketed as Depakote, Depakote
ER, Depakene, Depacon); Zonisamide (marketed as Zonegran). Some of these
drugs are also available in generic form.
Although only the drugs listed above were part of the analysis, the FDA
expects that all medications in the antiepileptic class share the increased
risk of suicidality.
FDA will be working with
manufacturers of marketed antiepileptic drugs to include this new
information in the labeling for these products.
For more information see
THIS LINK
or
THIS LINK.
Anti-malaria efforts yield new success
Widespread use of insecticide-treated mosquito
nets and state-of-the-art drugs has succeeded in cutting malaria deaths in
half in two countries most heavily affected by the disease, the
World Health Organization is
reporting. The findings from
Rwanda and
Ethiopia are the first to
show a greater than 50 percent reduction in malaria mortality nationwide in
"high burden" countries. Such dramatic reductions had been achieved
previously only in smaller regions or in countries where the disease is less
pervasive. The results suggest what may be possible in dozens of other
countries, and they are likely to spur efforts already underway to roll out
the relatively low-cost measures.
Malaria is responsible for 2 percent of all
deaths worldwide and 9 percent of deaths in
Africa. Each year, about 1.1
million deaths, almost all in children, are directly attributable to the
disease, and at least a million more occur from complications such as severe
anemia. In Africa, where most cases occur, malaria costs $12 billion a year
in medical expenses and lost productivity. "This is the first time we have
seen these results with the new tools," said Arata Kochi, head of malaria
programs for WHO. "This is a genuinely historic achievement," said Richard
G.A. Feachem, former director of the Global Fund to Fight AIDS, Tuberculosis
and Malaria who is now the director of the Global Health Group at the
University of California at San
Francisco. "This is not theoretical. We do not have to wait for a
vaccine or new drugs. If we implement today's technologies aggressively on a
national scale, we will have a big impact."
Two key items in the current "tool kit" are bed
nets treated with insecticide that lasts as much as five years, and
treatment with at least two drugs, one of them artemisinin, a compound
derived from a Chinese herbal medicine. The nets repel or kill mosquitoes
and work even if they have holes in them. When used by 80 percent of
households, the nets can reduce infections in African villages even among
people who do not have them, a phenomenon similar to the "herd immunity"
provided by vaccines. Artemisinin-containing therapies (ACTs) are oral drugs
that work quickly and are often life-saving when the brain is infected by
the malaria parasite. (Washington Post) See
THIS LINK.
MedAssets’ CrossWalk product enables accurate and defensible pricing of
medical supplies
MedAssets Inc. announced the release of version 3.0 of CrossWalk, the first
technology of its kind, created to automatically and continuously link
healthcare providers’ supply cost data to charge data to ensure that charges
adequately provide for defensible margins as compared to supply acquisition
costs. Initially launched in March 2005, CrossWalk links a hospital’s supply
item file to its chargemaster enabling a process by which mark up strategies
can be modeled before implementation to understand gross and net revenue
impact. The linkage also allows ongoing monitoring of the markup strategy
and provides the ability to continuously enforce accurate and defensible
pricing of supplies. Additionally, CrossWalk helps hospitals identify costly
items not in the supply item file and items that are being purchased
off-contract and outside of the standard purchasing processes.
CrossWalk is the keystone of the Merge Technology platform, MedAssets’ suite
of revenue and spend management solutions designed to solve healthcare
providers’ financial and operational problems and improve cash flow from
existing operations. MedAssets’ portfolio of revenue solutions promotes
revenue integrity by cleansing data and providing actionable information
that helps improve business processes and financial outcomes.
The
latest release of CrossWalk increases the accuracy and defensibility of
supply charges by allowing users to pull cost data from multiple sources,
including the supply item file and invoice records, and provides new and
improved cost validation. CrossWalk incorporates this more complete and
accurate cost data into the application and makes it readily viewable so
users can cross-check and identify discrepancies in their data. The
availability of this improved data also enhances reporting options within
CrossWalk and helps identify specific supply item file issues such as items
being purchased off-contract and items missing from the supply item file.
CrossWalk increases transparency into these costly occurrences and helps
hospitals better understand purchasing behavior so they can correct business
processes that are causing cash leakage.

back to home page |